Lindbrook Capital’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $31.6K | Buy |
620
+24
| +4% | +$1.22K | ﹤0.01% | 1165 |
|
2024
Q4 | $26.9K | Hold |
596
| – | – | ﹤0.01% | 1115 |
|
2024
Q3 | $22.1K | Sell |
596
-30
| -5% | -$1.11K | ﹤0.01% | 1241 |
|
2024
Q2 | $19.1K | Buy |
626
+105
| +20% | +$3.21K | ﹤0.01% | 1268 |
|
2024
Q1 | $15.2K | Hold |
521
| – | – | ﹤0.01% | 1357 |
|
2023
Q4 | $14.4K | Buy |
521
+492
| +1,697% | +$13.6K | ﹤0.01% | 1352 |
|
2023
Q3 | $650 | Buy |
29
+11
| +61% | +$247 | ﹤0.01% | 2465 |
|
2023
Q2 | $732 | Buy |
18
+10
| +125% | +$407 | ﹤0.01% | 2429 |
|
2023
Q1 | $388 | Buy |
8
+4
| +100% | +$194 | ﹤0.01% | 2651 |
|
2022
Q4 | $153 | Sell |
4
-36
| -90% | -$1.38K | ﹤0.01% | 2774 |
|
2022
Q3 | $2K | Buy |
40
+21
| +111% | +$1.05K | ﹤0.01% | 2121 |
|
2022
Q2 | $1K | Sell |
19
-4
| -17% | -$211 | ﹤0.01% | 2336 |
|
2022
Q1 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 2330 |
|
2021
Q2 | – | Sell |
-16
| Closed | -$1K | – | 1989 |
|
2021
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1768 |
|